Left Atrium Maximal Axial Cross-Sectional Area is a Specific Computed Tomographic Imaging Biomarker of World Health Organization Group 2 Pulmonary Hypertension - PubMed (original) (raw)
Left Atrium Maximal Axial Cross-Sectional Area is a Specific Computed Tomographic Imaging Biomarker of World Health Organization Group 2 Pulmonary Hypertension
Khalil Jivraj et al. J Thorac Imaging. 2017 Mar.
Abstract
Purpose: Left heart disease is associated with left atrial enlargement and is a common cause of pulmonary hypertension (PH). We investigated the relationship between left atrium maximal axial cross-sectional area (LA-MACSA), as measured on chest computed tomography (CT), and PH due to left heart disease (World Health Organization group 2) in patients with right heart catheterization-proven PH.
Materials and methods: A total of 165 patients with PH who had undergone right heart catheterization with pulmonary artery pressure and pulmonary capillary wedge pressure (PCWP) measurements and nongated chest CTs were included. LA-MACSA, LA anterior-posterior, and LA transverse measurements were independently obtained using the hand-drawn region-of-interest and distance measurement tools on standard PACS by 2 blinded cardiothoracic radiologists. Nonparametric statistical analyses and receiver operating characteristic curve were performed.
Results: Forty-three patients had group 2 PH (PCWP>15 mm Hg), and 122 had nongroup 2 PH (PCWP≤15 mm Hg). Median LA-MACSA was significantly different between the group 2 PH and nongroup 2 PH patients (2312 vs. 1762 mm, P<0.001). Interobserver concordance correlation for LA-MACSA was high at 0.91 (P<0.001). At a threshold of 2400 mm, LA-MACSA demonstrated 93% specificity for classifying group 2 PH (area under the curve, 0.73; P<0.001).
Conclusions: LA-MACSA is a readily obtainable and reproducible measurement of left atrial enlargement on CT and can distinguish between group 2 and nongroup 2 PH with high specificity.
Similar articles
- Identification of Pulmonary Hypertension Caused by Left-Sided Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived From Chest CT Imaging.
Aviram G, Rozenbaum Z, Ziv-Baran T, Berliner S, Topilsky Y, Fleischmann D, Sung YK, Zamanian RT, Guo HH. Aviram G, et al. Chest. 2017 Oct;152(4):792-799. doi: 10.1016/j.chest.2017.04.184. Epub 2017 May 12. Chest. 2017. PMID: 28506612 - Opportunistic Screening for Atrial Fibrillation on Routine Chest Computed Tomography.
Parker WA, Vigneault DM, Yang I, Bratt A, Marquardt AC, Sharifi H, Guo HH. Parker WA, et al. J Thorac Imaging. 2023 Sep 1;38(5):270-277. doi: 10.1097/RTI.0000000000000702. Epub 2023 Mar 6. J Thorac Imaging. 2023. PMID: 36917506 - Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group II pulmonary hypertension.
Purga SL, Karas MG, Horn EM, Torosoff MT. Purga SL, et al. J Echocardiogr. 2019 Dec;17(4):187-196. doi: 10.1007/s12574-018-0410-8. Epub 2018 Nov 24. J Echocardiogr. 2019. PMID: 30474820 - Left atrial size measured on CT pulmonary angiography: another parameter of pulmonary embolism severity? A systematic review.
Zuin M, Rigatelli G, Turchetta S, Zonzin P, Zuliani G, Roncon L. Zuin M, et al. J Thromb Thrombolysis. 2020 Jul;50(1):181-189. doi: 10.1007/s11239-019-01994-8. J Thromb Thrombolysis. 2020. PMID: 31754905 - Approach to Pulmonary Hypertension: From CT to Clinical Diagnosis.
Aluja Jaramillo F, Gutierrez FR, Díaz Telli FG, Yevenes Aravena S, Javidan-Nejad C, Bhalla S. Aluja Jaramillo F, et al. Radiographics. 2018 Mar-Apr;38(2):357-373. doi: 10.1148/rg.2018170046. Epub 2018 Feb 12. Radiographics. 2018. PMID: 29432063 Review.
Cited by
- Advanced imaging in pulmonary hypertension: emerging techniques and applications.
Rengier F, Melzig C, Derlin T, Marra AM, Vogel-Claussen J. Rengier F, et al. Int J Cardiovasc Imaging. 2019 Aug;35(8):1407-1420. doi: 10.1007/s10554-018-1448-4. Epub 2018 Aug 30. Int J Cardiovasc Imaging. 2019. PMID: 30168011 Review. - EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models.
Liu X, Zhang Y, Fu C, Zhang R, Zhou F. Liu X, et al. Front Genet. 2021 Apr 27;12:636429. doi: 10.3389/fgene.2021.636429. eCollection 2021. Front Genet. 2021. PMID: 33986767 Free PMC article. - Isolated Left Atrium Morphofunctional Study of an Experimental Pulmonary Hypertension Model in Rats.
Teixeira-Fonseca JL, Joviano-Santos JV, Machado FS, Silva PLD, Conceição MRL, Roman-Campos D. Teixeira-Fonseca JL, et al. Arq Bras Cardiol. 2023 Sep;120(10):e20230188. doi: 10.36660/abc.20230188. Arq Bras Cardiol. 2023. PMID: 37878960 Free PMC article. English, Portuguese. - EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).
Kiely DG, Levin D, Hassoun P, Ivy DD, Jone PN, Bwika J, Kawut SM, Lordan J, Lungu A, Mazurek J, Moledina S, Olschewski H, Peacock A, Puri GD, Rahaghi F, Schafer M, Schiebler M, Screaton N, Tawhai M, Van Beek EJ, Vonk-Noordegraaf A, Vanderpool RR, Wort J, Zhao L, Wild J, Vogel-Claussen J, Swift AJ. Kiely DG, et al. Pulm Circ. 2019 Mar 18;9(3):2045894019841990. doi: 10.1177/2045894019841990. Online ahead of print. Pulm Circ. 2019. PMID: 30880632 Free PMC article. - Automated volumetry of core and peel intrapulmonary vasculature on computed tomography angiography for non-invasive estimation of hemodynamics in patients with pulmonary hypertension (2022 updated hemodynamic definition).
Melzig C, Weinheimer O, Egenlauf B, Do TD, Wielpütz MO, Grünig E, Kauczor HU, Heussel CP, Rengier F. Melzig C, et al. Cardiovasc Diagn Ther. 2024 Dec 31;14(6):1083-1095. doi: 10.21037/cdt-24-293. Epub 2024 Dec 19. Cardiovasc Diagn Ther. 2024. PMID: 39790187 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials